Oxygen saturation as a predictor of mortality in hospitalized adult patients with COVID-19 in a public hospital in Lima, Peru.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2020
Historique:
received: 13 08 2020
accepted: 06 12 2020
entrez: 28 12 2020
pubmed: 29 12 2020
medline: 12 1 2021
Statut: epublish

Résumé

Peru is among the top ten countries with the highest number of coronavirus disease 2019 (COVID-19) cases worldwide. The aim of the study was to describe the clinical features of hospitalized adult patients with COVID-19 and to determine the prognostic factors associated with in-hospital mortality. We conducted a retrospective cohort study among adult patients with COVID-19 admitted to Hospital Cayetano Heredia; a tertiary care hospital in Lima, Peru. The primary outcome was in-hospital mortality. Multivariate Cox proportional hazards regression was used to identify factors independently associated with in-hospital mortality. A total of 369 patients (median age 59 years [IQR:49-68]; 241 (65.31%) male) were included. Most patients (68.56%) reported at least one comorbidity; more frequently: obesity (42.55%), diabetes mellitus (21.95%), and hypertension (21.68%). The median duration of symptoms prior to hospital admission was 7 days (IQR: 5-10). Reported in-hospital mortality was 49.59%. By multiple Cox regression, oxygen saturation (SaO2) values of less than 90% on admission correlated with mortality, presenting 1.86 (95%CI: 1.02-3.39), 4.44 (95%CI: 2.46-8.02) and 7.74 (95%CI: 4.54-13.19) times greater risk of death for SaO2 of 89-85%, 84-80% and <80%, respectively, when compared to patients with SaO2 >90%. Additionally, age >60 years was associated with 1.88 times greater mortality. Oxygen saturation below 90% on admission is a strong predictor of in-hospital mortality in patients with COVID-19. In settings with limited resources, efforts to reduce mortality in COVID-19 should focus on early identification of hypoxemia and timely access to hospital care.

Identifiants

pubmed: 33370364
doi: 10.1371/journal.pone.0244171
pii: PONE-D-20-25433
pmc: PMC7769479
doi:

Substances chimiques

Oxygen S88TT14065

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0244171

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

JAMA. 2010 Dec 8;304(22):2521-7
pubmed: 21139113
JAMA. 2020 Feb 25;323(8):709-710
pubmed: 31999307
Clin Infect Dis. 2020 Nov 19;71(16):2079-2088
pubmed: 32361723
Acad Emerg Med. 2020 Aug;27(8):681-692
pubmed: 32779828
Rev Invest Clin. 2020;72(3):151-158
pubmed: 32584330
Int J Med Sci. 2020 May 18;17(9):1281-1292
pubmed: 32547323
Respir Res. 2020 Jul 28;21(1):198
pubmed: 32723327
PLoS One. 2015 Sep 15;10(9):e0136166
pubmed: 26372640
BMJ. 2020 May 22;369:m1966
pubmed: 32444366
Health Econ. 2017 Dec;26(12):e179-e203
pubmed: 28205370
N Engl J Med. 2011 Feb 17;364(7):656-65
pubmed: 21323543
Epidemiol Infect. 2020 Jun 25;148:e123
pubmed: 32580809
Mayo Clin Proc. 2020 Jun;95(6):1138-1147
pubmed: 32376101
JAMA. 2020 Apr 7;323(13):1239-1242
pubmed: 32091533
Clin Infect Dis. 2020 Jul 28;71(15):896-897
pubmed: 32271368
JAMA. 2020 May 26;323(20):2052-2059
pubmed: 32320003
Lancet. 2020 Mar 28;395(10229):1054-1062
pubmed: 32171076
Clin Infect Dis. 2020 Aug 17;:
pubmed: 32803236
Travel Med Infect Dis. 2020 Mar - Apr;34:101623
pubmed: 32179124
Rev Peru Med Exp Salud Publica. 2013 Oct-Dec;30(4):676-82
pubmed: 24448948
Am J Physiol Endocrinol Metab. 2020 May 1;318(5):E736-E741
pubmed: 32228322
Crit Care Clin. 2006 Jul;22(3):439-46, viii
pubmed: 16893731
Rev Peru Med Exp Salud Publica. 2020 Apr-Jun;37(2):203-209
pubmed: 32876207
JAMA. 2012 Jun 20;307(23):2526-33
pubmed: 22797452
Diabetes Metab Syndr. 2020 Jul - Aug;14(4):655-659
pubmed: 32438328
Int J Infect Dis. 2020 May;94:91-95
pubmed: 32173574
Lancet. 2020 Jun 6;395(10239):1763-1770
pubmed: 32442528
JAMA. 2020 Jun 2;323(21):2195-2198
pubmed: 32329797
Lancet Respir Med. 2020 May;8(5):475-481
pubmed: 32105632

Auteurs

Fernando Mejía (F)

Instituto de Medicina Tropical Alexander von Humboldt, Universidad Peruana Cayetano Heredia, Lima, Peru.
Hospital Cayetano Heredia, Lima, Peru.

Carlos Medina (C)

Instituto de Medicina Tropical Alexander von Humboldt, Universidad Peruana Cayetano Heredia, Lima, Peru.
Hospital Cayetano Heredia, Lima, Peru.

Enrique Cornejo (E)

Instituto de Medicina Tropical Alexander von Humboldt, Universidad Peruana Cayetano Heredia, Lima, Peru.
Hospital Cayetano Heredia, Lima, Peru.

Enrique Morello (E)

Hospital Cayetano Heredia, Lima, Peru.

Sergio Vásquez (S)

Hospital Cayetano Heredia, Lima, Peru.

Jorge Alave (J)

Hospital Cayetano Heredia, Lima, Peru.
School of Medicine, Universidad Peruana Unión, Lima, Peru.

Alvaro Schwalb (A)

Instituto de Medicina Tropical Alexander von Humboldt, Universidad Peruana Cayetano Heredia, Lima, Peru.

Germán Málaga (G)

Hospital Cayetano Heredia, Lima, Peru.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH